LeMaitre George W. - 19 Dec 2022 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role: Chairman and CEO, Director, 10%+ Owner
Signature: /s/ Laurie A. Churchill, Attorney-in-fact
Issuer symbol: LMAT
Transactions as of: 19 Dec 2022
Net transactions value: +$264,006
Form type: 4
Filing time: 21 Dec 2022, 19:49:40 UTC
Previous filing: 13 Dec 2022
Next filing: 27 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LMAT	Common Stock	Options Exercise	$0	+63	+0%	$0.000000	2,497,015	19 Dec 2022	Direct	F1
transaction	LMAT	Common Stock	Tax liability	$21,818	-477	-0.02%	$45.74	2,496,538	19 Dec 2022	Direct	F2
transaction	LMAT	Common Stock	Options Exercise	$0	+29	+0%	$0.000000	2,496,567	20 Dec 2022	Direct	F1
transaction	LMAT	Common Stock	Tax liability	$14,496	-312	-0.01%	$46.46	2,496,255	20 Dec 2022	Direct	F3
transaction	LMAT	Common Stock	Options Exercise	$300,319	+12,747	+0.51%	$23.56	2,509,002	20 Dec 2022	Direct	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LMAT	Dividend Equivalent Rights	Options Exercise	$0	-63	-47%	$0.000000	71	19 Dec 2022	Common Stock	63		Direct	F5
transaction	LMAT	Dividend Equivalent Rights	Options Exercise	$0	-29	-30%	$0.000000	67	20 Dec 2022	Common Stock	29		Direct	F6
transaction	LMAT	Stock Option (Right to Buy)	Options Exercise	$0	-12,747	-50%	$0.000000	12,747	20 Dec 2022	Common Stock	12,747	$23.56	Direct	F7, F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F2	These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 19, 2018. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
F3	These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 20, 2019. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
F4	Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F5	These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F6	These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F7	This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining four years, with the final vesting occurring on the 11th month after the fourth anniversary.
F8	The expiration date of this option to the extent it is an incentive stock option is 12/19/2023, and the expiration date of this option to the extent it is a nonqualified stock option is 12/19/2025.